RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Core Viewpoint - RxSight, Inc. will report its financial results for Q4 and full year 2025 on February 25, 2026, with a conference call scheduled for discussion of these results [1]. Company Overview - RxSight, Inc. is an ophthalmic medical device company focused on providing high-quality customized vision for patients post-cataract surgery [3]. - The company offers the RxSight® Light Adjustable Lens system, which is the first and only commercially available intraocular lens technology that can be adjusted after surgery, allowing for customization of vision quality [3]. Conference Call Details - The conference call to discuss financial results can be accessed by dialing (800) 715-9871 or (646) 307-1963, with a conference code of 3406720 [2]. - The call will also be available in listen-only mode via the company's investor relations website, with an archived recording accessible shortly after the call [2].